NEVVI Medicare utilization intelligence

← back

LAMON, JOELMD NPI 1699721035 Clinician

Hematology-Oncology · SAN DIEGO, CA

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 53 years since medical school (class of 1973, self-reported to CMS)
Location SAN DIEGO, CA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 49 codes billed · 170,620 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
CALIFORNIA CANCER ASSOCIATES FOR RESEARCH AND EXCELLENCE INC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2013-11

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J0185 Injection, aprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1627 Injection, granisetron, extended-release, 0.1 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J2469 Injection, palonosetron hcl, 25 mcg
36415 Insertion of needle into vein for collection of blood sample
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
J2919 Injection, methylprednisolone sodium succinate, 5 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J9190 Injection, fluorouracil, 500 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J3490 Unclassified drugs
J1200 Injection, diphenhydramine hcl, up to 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96375 Injection of additional new drug or substance into vein
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J1954 Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
96411 Administration of additional new drug or substance into vein using push technique
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
80053 Blood test, comprehensive group of blood chemicals
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
78816 Nuclear medicine study whole body with ct scan
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
99442 Telephone medical discussion with physician, 11-20 minutes
38222 Biopsy and aspiration of bone marrow sample for diagnosis

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.